Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Accounts receivable | -6.91%70.33M | -19.98%76.59M | -23.35%75.1M | -36.25%68.23M | -34.96%75.55M | -52.29%95.71M | -52.53%97.98M | -45.65%107.04M | 9.92%116.15M | 105.66%200.6M |
| Notes receivable | 152.62%74.91M | ---- | -35.80%62.06M | ---- | -78.46%29.65M | ---- | -11.88%96.67M | ---- | -30.70%137.68M | ---- |
| Advance deposits and other receivables | -7.81%10.08M | ---- | -11.67%9.46M | ---- | -16.23%10.94M | ---- | -17.77%10.71M | ---- | -59.40%13.06M | ---- |
| Cash and equivalents | -17.23%7.2B | -13.67%7.33B | -3.71%10.06B | -19.85%7.48B | 3.14%8.7B | -4.59%8.49B | 11.64%10.45B | 52.52%9.34B | 14.61%8.43B | -3.79%8.9B |
| Financial assets at fair value-current assets | 50.39%780.82M | 24.00%684.68M | 76.71%1.1B | -42.88%631.27M | -45.56%519.21M | -35.35%552.14M | -29.43%620.44M | 82.38%1.11B | 18.79%953.77M | -40.89%853.99M |
| Derivative financial instruments-current assets | ---- | -90.64%9.81M | ---- | 9.24%96.43M | ---- | -40.78%104.84M | ---- | -22.13%88.28M | ---- | 103.59%177.05M |
| Other current assets | -80.66%241.98M | ---- | -32.66%655.12M | ---- | 29.01%1.25B | ---- | 0.07%972.88M | ---- | 8.87%970.05M | ---- |
| Special items of current assets | -0.24%43.59B | 0.51%38.75B | -7.59%43.08B | -5.30%38.27B | -9.72%43.69B | -6.99%38.55B | -5.46%46.62B | 5.71%40.41B | 1.16%48.4B | 34.15%41.45B |
| Total current assets | -4.27%51.98B | -5.38%52.53B | -6.69%55.12B | -10.90%53.19B | -8.06%54.29B | -9.15%55.52B | -3.00%59.07B | 3.59%59.69B | 3.08%59.05B | 3.28%61.1B |
| Non-current assets | ||||||||||
| Fixed assets | -7.95%6.29B | ---- | -2.85%6.66B | ---- | -2.21%6.84B | ---- | -0.64%6.86B | ---- | 25.79%6.99B | ---- |
| Property, plant and equipment | ---- | -3.75%6.73B | ---- | -2.92%6.92B | ---- | -4.78%6.99B | ---- | -2.46%7.13B | ---- | 30.93%7.34B |
| Long-term receivables | 6.57%49.77B | ---- | -3.28%48.08B | ---- | -14.37%46.7B | ---- | -11.39%49.71B | ---- | 6.91%54.53B | ---- |
| Financial assets at fair value-non-current assets | ---- | -14.75%13.24M | ---- | -52.99%11.65M | ---- | -83.97%15.53M | ---- | -76.91%24.79M | ---- | -15.86%96.85M |
| Intangible assets | 8.57%68.06M | 38.47%72.83M | 38.30%74.53M | 38.71%79.45M | 94.33%62.68M | 140.07%52.6M | 180.94%53.89M | 221.01%57.28M | 117.29%32.26M | 64.94%21.91M |
| Deferred tax assets | 9.02%1.89B | 7.33%1.81B | -0.16%1.92B | 0.14%1.86B | -1.19%1.74B | 0.13%1.68B | 20.32%1.92B | 10.69%1.86B | 17.15%1.76B | 18.10%1.68B |
| Other illiquid assets | -72.76%258.85M | 4.85%2.68B | -65.48%367.34M | -11.13%2.41B | -24.18%950.18M | -11.29%2.55B | -12.34%1.06B | -2.22%2.72B | -55.66%1.25B | 20.47%2.88B |
| Special items of non-current assets | -23.10%6.43M | 8.60%39.19B | -44.14%7.06M | -6.54%37.94B | -67.30%8.37M | -23.48%36.08B | -65.76%12.65M | -15.16%40.59B | -49.60%25.58M | 19.67%47.16B |
| Total non-current assets | 3.52%58.33B | 1.80%58.6B | -4.23%57.15B | -8.71%58.11B | -12.87%56.34B | -14.96%57.57B | -9.61%59.67B | -4.83%63.66B | 5.80%64.67B | 18.71%67.69B |
| Total assets | -0.30%110.31B | -1.72%111.13B | -5.45%112.27B | -9.77%111.3B | -10.58%110.64B | -12.20%113.08B | -6.44%118.75B | -0.93%123.35B | 4.48%123.72B | 10.85%128.8B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | -26.71%1.72B | -94.52%27.91M | -33.07%1.71B | -5.45%261.95M | -2.88%2.34B | 213.90%509.55M | -6.87%2.55B | 37.32%277.03M | -34.29%2.41B | 2,965.68%162.33M |
| Notes payable | 5.15%2.02B | ---- | 4.67%1.51B | ---- | 55.31%1.92B | ---- | -19.49%1.44B | ---- | -16.85%1.24B | ---- |
| Tax payable | 2.77%386.65M | -6.20%271.4M | -13.36%580.74M | -31.48%389.29M | -18.46%376.23M | -17.20%289.34M | -0.01%670.26M | -16.40%568.11M | 15.32%461.42M | 12.04%349.45M |
| Other payables and accrued expenses | 29.17%756.96M | ---- | -42.71%410.36M | ---- | -50.78%586.02M | ---- | -41.31%716.26M | ---- | -45.36%1.19B | ---- |
| Advance payment | -51.20%22.85M | ---- | -0.47%28.31M | ---- | 42.15%46.82M | ---- | 13.55%28.44M | ---- | 30.03%32.94M | ---- |
| Short-term borrowing | -29.88%2.91B | ---- | -27.85%3.9B | ---- | -25.77%4.15B | ---- | -33.94%5.41B | ---- | -28.31%5.59B | ---- |
| Bank loans and overdrafts | ---- | 0.46%22.71B | ---- | 0.83%23.88B | ---- | -9.37%22.61B | ---- | -7.73%23.69B | ---- | -6.71%24.94B |
| Derivative financial instrument-current liabilities | ---- | -90.23%4.25M | ---- | 309.49%23.42M | ---- | 603.12%43.52M | ---- | -92.49%5.72M | ---- | -94.29%6.19M |
| Other current liabilities | -85.68%114.41M | ---- | -60.18%259.09M | ---- | 67.96%799.14M | ---- | 172.97%650.66M | ---- | 150.41%475.78M | ---- |
| Special items of current liabilities | 11.10%40.84B | 15.65%28.26B | 16.78%44.7B | -2.56%28.57B | -8.83%36.76B | -25.68%24.43B | -8.96%38.28B | -5.19%29.33B | -1.63%40.32B | 12.84%32.87B |
| Total current liabilities | 3.59%48.93B | 7.08%51.27B | 6.51%53.17B | -1.36%53.13B | -9.34%47.23B | -17.92%47.88B | -12.69%49.92B | -6.42%53.87B | -8.68%52.09B | 3.62%58.34B |
| Net current assets | -56.82%3.05B | -83.50%1.26B | -78.66%1.95B | -99.08%53.55M | 1.48%7.06B | 175.71%7.63B | 145.89%9.15B | 9,001.31%5.83B | 2,743.14%6.96B | -3.42%2.77B |
| Total assets less current liabilities | -3.20%61.38B | -8.19%59.86B | -14.13%59.1B | -16.29%58.16B | -11.48%63.41B | -7.47%65.2B | -1.31%68.82B | 3.78%69.49B | 16.72%71.63B | 17.65%70.46B |
| Non-current liabilities | ||||||||||
| Long-term bank loan | 11.16%19.17B | -5.49%17.76B | -14.03%17.48B | -26.58%16.23B | -22.90%17.25B | -20.39%18.8B | -13.64%20.33B | -4.50%22.11B | 10.75%22.37B | 17.58%23.61B |
| Long-term accounts payable | -0.12%4.45B | ---- | -4.91%4.51B | ---- | -13.57%4.46B | ---- | -14.05%4.74B | ---- | -3.87%5.16B | ---- |
| Financial lease liabilities-non-current liabilities | 13.48%13.01M | ---- | -1.11%11.15M | ---- | -34.70%11.46M | ---- | -32.97%11.27M | ---- | -20.75%17.55M | ---- |
| Deferred tax liability | -15.04%17.39M | 15.67%20.13M | 34.08%20.64M | 32.60%17.43M | 9.47%20.46M | -4.10%17.4M | 1.46%15.39M | -1.61%13.15M | 19.89%18.69M | 20.97%18.14M |
| Deferred income-non-current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -12.43%59.15M | ---- |
| Convertible notes and bonds | ---- | -20.39%16.91B | ---- | -21.15%17.08B | ---- | -1.16%21.24B | ---- | 16.00%21.66B | ---- | 32.78%21.49B |
| Other non-current liabilities | -17.19%265.49M | -3.20%4.79B | -37.04%336.07M | -11.14%4.86B | -41.02%320.59M | -15.80%4.95B | -20.85%533.81M | -13.20%5.46B | 57.03%543.55M | 2.36%5.88B |
| Special items of non-current liabilities | -17.42%17.16B | ---- | -28.73%16.36B | ---- | -10.14%20.78B | ---- | 13.37%22.95B | ---- | 33.31%23.13B | ---- |
| Total non-current liabilities | -4.10%41.08B | -12.26%39.49B | -20.32%38.71B | -22.46%38.18B | -16.48%42.84B | -11.75%45.01B | -3.04%48.59B | 2.32%49.24B | 18.29%51.29B | 21.36%51B |
| Total liabilities | -0.07%90.01B | -2.29%90.76B | -6.73%91.88B | -11.44%91.31B | -12.88%90.07B | -15.04%92.89B | -8.18%98.51B | -2.44%103.11B | 2.96%103.39B | 11.20%109.34B |
| Total assets less total liabilities | -1.33%20.3B | 0.89%20.37B | 0.74%20.39B | -1.30%19.98B | 1.14%20.57B | 3.75%20.19B | 3.10%20.24B | 7.54%20.25B | 12.95%20.34B | 8.92%19.46B |
| Total equity and non-current liabilities | -3.20%61.38B | -8.19%59.86B | -14.13%59.1B | -16.29%58.16B | -11.48%63.41B | -7.47%65.2B | -1.31%68.82B | 3.78%69.49B | 16.72%71.63B | 17.65%70.46B |
| Equity | ||||||||||
| Share capital | 0.00%8.24B | 0.00%8.24B | 0.00%8.24B | 0.00%8.24B | 0.00%8.24B | 0.00%8.24B | 0.00%8.24B | 0.00%8.24B | 0.00%8.24B | 0.00%8.24B |
| Other equity instruments | -20.65%2.37B | -16.65%2.46B | -16.94%2.49B | -28.03%2.47B | -13.09%2.98B | 1.06%2.96B | -0.91%3B | 29.81%3.43B | 61.75%3.43B | 37.61%2.93B |
| Capital reserve | -0.02%2.47B | -0.14%2.46B | -0.23%2.47B | -0.26%2.46B | -0.26%2.47B | -0.28%2.46B | -0.55%2.47B | -0.74%2.47B | -0.74%2.47B | -0.59%2.47B |
| Exchange reserve | ---- | 17.48%39.67M | ---- | 45.43%39.63M | ---- | -35.81%33.77M | ---- | 220.40%27.25M | ---- | 256.09%52.6M |
| Other reserves | ---- | -33.25%74.01M | ---- | -5.97%92.25M | ---- | -9.88%110.88M | ---- | 43.78%98.11M | ---- | 97.68%123.04M |
| Retained profit | ---- | 11.16%6.13B | ---- | 11.84%5.71B | ---- | 12.59%5.51B | ---- | 10.42%5.11B | ---- | 12.03%4.89B |
| Undistributed profit | 4.09%6.16B | ---- | 10.88%6.11B | ---- | 12.62%5.92B | ---- | 9.58%5.51B | ---- | 19.81%5.26B | ---- |
| Shareholders' Equity | -1.35%20.24B | 0.88%20.31B | 0.73%20.33B | -1.33%19.93B | 1.11%20.51B | 3.72%20.14B | 3.07%20.18B | 7.53%20.2B | 12.94%20.29B | 8.89%19.42B |
| Non-controlling interest | 7.16%59.06M | 6.92%58.06M | 6.81%57.09M | 13.32%56.02M | 15.02%55.11M | 15.31%54.31M | 18.32%53.45M | 11.65%49.44M | 20.38%47.91M | 19.38%47.1M |
| Total equity | -1.33%20.3B | 0.89%20.37B | 0.74%20.39B | -1.30%19.98B | 1.14%20.57B | 3.75%20.19B | 3.10%20.24B | 7.54%20.25B | 12.95%20.34B | 8.92%19.46B |
| Total equity and total liabilities | -0.30%110.31B | -1.72%111.13B | -5.45%112.27B | -9.77%111.3B | -10.58%110.64B | -12.20%113.08B | -6.44%118.75B | -0.93%123.35B | 4.48%123.72B | 10.85%128.8B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | PwC, PwC Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.